Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Oshima

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Internal Medicine (Tokyo, Japan)|April 19, 2011
Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug AdministrationYasuo Oshima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 9, 2011
[Series: For attending physicians; professionalism; causality assessment between reported adverse events and suspected drugs]Yasuo Oshima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 10, 2012
[Why is the incidence of post-vaccination interstitial pneumonia high in Japan?]Yasuo Oshima, Arinobu Tojo
International Journal of Hematology|August 23, 2011
Pulmonary alveolar hemorrhage possibly associated with lenalidomide useYasuo Oshima, Arinobu Tojo
International Journal of Hematology|August 31, 2011
Attractive tools for systematic case accumulationYasuo Oshima, Arinobu Tojo
Blood|June 18, 2002
Implication for how the single nucleotide polymorphism (SNP) of Fc receptor, Fc gamma RIIIa alters the interaction with anti-CD20 monoclonal antibodyYasuo Oshima, Akio Fujimura
Cytokine|October 17, 2003
Function of a conserved residue in the amino terminal alpha-helix of four helical bundle cytokinesYasuo Oshima, Akio Fujimura
The New England Journal of Medicine|June 5, 2014
23andMe and the FDAKoichiro Yuji, Tetsuya Tanimoto, Yasuo Oshima
The New England Journal of Medicine|September 21, 2012
Eltrombopag in refractory aplastic anemiaYasuo Oshima, Koichiro Yuji, Arinobu Tojo
The New England Journal of Medicine|October 15, 2010
Interstitial lung disease and gefitinibNaoko Murashige, Tetsuya Tanimoto, Yasuo Oshima
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Internal Medicine (Tokyo, Japan)|April 19, 2011
Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug AdministrationYasuo Oshima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 9, 2011
[Series: For attending physicians; professionalism; causality assessment between reported adverse events and suspected drugs]Yasuo Oshima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 10, 2012
[Why is the incidence of post-vaccination interstitial pneumonia high in Japan?]Yasuo Oshima, Arinobu Tojo
International Journal of Hematology|August 23, 2011
Pulmonary alveolar hemorrhage possibly associated with lenalidomide useYasuo Oshima, Arinobu Tojo
International Journal of Hematology|August 31, 2011
Attractive tools for systematic case accumulationYasuo Oshima, Arinobu Tojo
Blood|June 18, 2002
Implication for how the single nucleotide polymorphism (SNP) of Fc receptor, Fc gamma RIIIa alters the interaction with anti-CD20 monoclonal antibodyYasuo Oshima, Akio Fujimura
Cytokine|October 17, 2003
Function of a conserved residue in the amino terminal alpha-helix of four helical bundle cytokinesYasuo Oshima, Akio Fujimura
The New England Journal of Medicine|June 5, 2014
23andMe and the FDAKoichiro Yuji, Tetsuya Tanimoto, Yasuo Oshima
The New England Journal of Medicine|September 21, 2012
Eltrombopag in refractory aplastic anemiaYasuo Oshima, Koichiro Yuji, Arinobu Tojo
The New England Journal of Medicine|October 15, 2010
Interstitial lung disease and gefitinibNaoko Murashige, Tetsuya Tanimoto, Yasuo Oshima
Pageof 4